查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生理節律睡眠障礙的全球市場到2030年預測：按治療類型、藥物類型、年齡、配銷通路、應用、最終用戶和地區進行分析
市場調查報告書
商品編碼
1383349

生理節律睡眠障礙的全球市場到2030年預測：按治療類型、藥物類型、年齡、配銷通路、應用、最終用戶和地區進行分析

Circadian Rhythm Seep Disorder Market Forecasts to 2030 - Global Analysis By Treatment Type, Drug Type, Age, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2023年全球生理節律睡眠障礙市場規模為 7.6187 億美元，預計到2030年將達到 11.9174 億美元，預測期內年複合成長率為 6.6%。

生理節律睡眠障礙是指晝夜節律（人體的內在手錶）出現異常的情況。與晝夜節律相關的睡眠障礙是由外在環境和中樞晝夜計時系統的變化所帶來的。如果難以按時入睡並且睡眠時間表被打亂，那麼通常患有生理節律睡眠障礙。生理節律睡眠障礙有多種類型，包括時差型、輪班工作障礙、提前睡眠相位障礙（ASPS）、延遲睡眠相位障礙（DSPD）和無規則型。

根據睡眠心臟研究，有失眠或睡眠不足史的人罹患心血管疾病（CVD）的風險增加 29%。這些數字鼓勵患有睡眠障礙的人尋求專業協助並增加市場需求。

改善識別和診斷

公共衛生配合措施、教育宣傳活動以及透過數位平台普及資訊的力度加大，人們對生理節律睡眠障礙的認知不斷提高。此外，診斷率的提高是患者和醫療保健提供者對 CRSD徵兆和症狀的認知提高的結果。隨著診斷普及越來越普遍，越來越多的人尋求適當的治療和管理方案，這推動市場擴張。

知識和意識不足

CRSD 市場的一個主要障礙是缺乏對與晝夜節律相關的睡眠障礙的知識和認知。公眾和醫療專業人員可能都無法識別這些症狀或將其誤認為是其他疾病。此外，這種無知可能會導致診斷不足和治療延遲，阻礙市場擴張。

研發進度

對睡眠障礙的晝夜節律、遺傳學和神經生物學的持續研究使得針對 CRSD 各種亞型的新診斷設備、治療性介入和藥物的開發成為可能。此外，這項研究是改善患者治療效果和更有效治療的關鍵。

認知不足、誤診

公眾和醫療保健相關人員對這些疾病的認知較低，對 CRSD 市場構成嚴重威脅。許多患有 CRSD 的人未被診斷或誤診，並且經常將他們的症狀歸咎於其他疾病。然而，知識不足阻礙了快速診斷和有效治療。

COVID-19 的影響

生理節律睡眠障礙（CRSD）市場受到 COVID-19大流行的各種影響。在大流行最嚴重的時候，患者就診的減少，醫療保健服務的變化以及 COVID-19 病例的優先處理導致了 CRSD 診斷和治療的延遲。睡眠診所的暫時關閉及其運作限制影響了患者獲得治療的機會。此外，睡眠障礙的增加是由於生活方式的改變和大流行帶來的心理壓力。

燈箱細分市場預計將成為預測期內最大的細分市場

燈箱細分市場在生理節律睡眠障礙市場中佔有最大佔有率。 CRSD 的重要非藥物治療之一是光療，通常透過燈箱進行。對於輪班工作睡眠障礙和睡眠時相延遲障礙等疾病尤其如此。此外，燈箱產生的明亮人造光可以透過模擬陽光來幫助重置人的晝夜節律。燈箱在臨床和家庭中廣泛使用，可成功管理 CRSD 症狀。光療法廣泛應用於CRSD的治療計劃中，並且由於其非侵入性且有效，在「燈箱」類別中擁有很大的市場佔有率。

健康中心和水療中心部門預計在預測期內年複合成長率最高

生理節律睡眠障礙（CRSD）市場預計將在健康中心和水療中心領域實現最高的年複合成長率。健康中心和水療中心擴大在其菜單中添加睡眠健康服務，包括放鬆療法和以 CRSD 為重點的治療。此外，這些設置還提供針對睡眠障礙的全面治療策略，強調放鬆和整體健康。隨著人們越來越意識到睡眠與健康之間的聯繫，他們開始轉向健康中心和水療中心尋求專業的治療和療法。

比例最高的地區：

北美（包括美國和加拿大）通常佔據生理節律睡眠障礙（CRSD）的最大市場佔有率佔有率。此外，該地區完善的醫療保健體系，出色的研發工作，睡眠障礙的高發病率以及人們對睡眠健康重要性的認知不斷增強是這一優勢的主要原因。該地區由於其富裕程度和睡眠障礙發病率高而成為 CRSD 市場的領導者，使其成為睡眠醫學領域創新和發展的中心。

年複合成長率最高的地區：

生理節律睡眠障礙（CRSD）市場預計將成為亞太地區最高的年複合成長率。該地區的強勁成長得益於多種因素，包括睡眠衛生意識的提高，生活方式的變化導致 CRSD 發病率的增加以及醫療設施的發展。人們對整體健康和福祉的日益重視，加上亞太地區的經濟擴張，推動對治療睡眠障礙的創新方法的需求。此外，由於都市化、醫療保健支出增加和中階擴大等因素，亞太地區 CRSD 市場經歷快速成長。因此，該市場被定位為一個充滿活力且快速擴張的細分市場，未來市場開拓備受期待。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計/預測/年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球生理節律睡眠障礙市場：依治療類型

  • 介紹
  • 治療設備
  • 燈箱
  • 檯燈
  • 遮光板
  • 黎明模擬器
  • 診斷設備
  • 體動記錄感測器
  • 手腕和手帶體動記錄儀
  • 穿戴式體動記錄儀
  • 睡眠多項生理檢查
  • 固定式睡眠多項生理檢查測試裝置
  • 攜帶式
  • 藥品
  • 其他治療類型

第6章 全球生理節律睡眠障礙市場：依藥物類型

  • 介紹
  • 苯二氮平類
  • 非苯二氮平類安眠藥
  • Orexin受體拮抗
  • 褪黑激素受體促效劑
  • 莫達非尼
  • 他司美瓊
  • 其他

第7章 全球生理節律睡眠障礙市場：依年齡分類

  • 介紹
  • 嬰兒
  • 成人
  • 老年人

第8章 全球生理節律睡眠障礙市場：依配銷通路

  • 介紹
  • 企業銷售
  • 零售

第9章 全球生理節律睡眠障礙市場：依應用分類

  • 介紹
  • 睡眠時相延遲綜合症
  • 晚期睡眠階段綜合症
  • 非24小時睡眠覺醒綜合症
  • 不規則的睡眠/覺醒障礙
  • 輪班工作障礙
  • 時差
  • 其他用途

第10章 全球生理節律睡眠障礙市場：依最終用戶分類

  • 介紹
  • 居家醫療
  • 健康中心和水療中心
  • 睡眠測試中心
  • 專科診所
  • 其他最終用戶

第11章 全球生理節律睡眠障礙市場：依地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第12章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司簡介

  • Carex Health
  • The Sunbox Company
  • Garmin Ltd.
  • BMC Medical Co., Ltd
  • Teva Pharmaceutical Industries Ltd.
  • Natus Medical Incorporated
  • Koninklijke Philips NV
  • Mylan NV
  • Vanda Pharmaceuticals Inc.
  • Neuraxpharm
  • Sunrise System
  • Beurer GmbH
  • Lanaform NV
  • Samarit Medical AG
  • Takeda Pharmaceutical Company
  • Northern Light Technologies
  • RedMed Inc.
  • ActiGraph, LLC
  • Verilux, Inc.
  • Akeda Pharmaceutical Company Limited
Product Code: SMRC24199

According to Stratistics MRC, the Global Circadian Rhythm Seep Disorder Market is accounted for $761.87 million in 2023 and is expected to reach $1191.74 million by 2030 growing at a CAGR of 6.6% during the forecast period. The term circadian rhythm sleep disorders (CRSDs) refers to conditions where the body's internal clock, the circadian rhythms, are abnormal. Sleep disorders related to the circadian rhythm are brought on by changes in the external environment and the central circadian timekeeping system. When a person struggles to go to sleep at a regular time and interferes with their sleep schedule, they usually have circadian rhythm sleep disorders. And, there are various types of circadian rhythm sleep disorders, including jet lag, shift work disorder, advanced sleep phase disorder (ASPS), delayed sleep phase disorder (DSPD), and the free-running type.

According to a sleep heart study, those who had a history of insomnia or poor sleep had a 29 % increased risk of cardiovascular disease (CVD). These kinds of figures encourage those suffering from sleep disorders to seek expert assistance, hence raising the market's demand.

Market Dynamics:

Driver:

Increasing awareness and diagnosis

Increased public health efforts, education campaigns, and the spread of information via digital platforms are all responsible for the rising awareness of circadian rhythm sleep disorders. Additionally, rising diagnosis rates are a result of patients and medical professionals' increased awareness of the telltale signs and symptoms of CRSDs. Growing numbers of people are seeking suitable treatment and management options as diagnosis becomes more widely available, which propels market expansion.

Restraint:

Inadequate knowledge and awareness

A major barrier to the CRSD market is the lack of knowledge and awareness regarding sleep disorders related to the circadian rhythm. Both the general public and medical professionals might not be aware of the symptoms or might mistake them for other illnesses. Moreover, this ignorance may result in under diagnosis and postponed treatment, impeding the expansion of the market.

Opportunity:

Advances in research and development

The development of novel diagnostic instruments, therapeutic interventions, and pharmaceuticals specifically designed for various subtypes of CRSDs is made possible by ongoing research into circadian rhythms, genetics, and the neurobiology of sleep disorders. Additionally, this study holds the key to improved patient outcomes and more potent treatments.

Threat:

Insufficient knowledge and misdiagnosis

The low awareness of these disorders among the general public and medical professionals poses a serious threat to the CRSD market. Many people with CRSDs go undiagnosed or are misdiagnosed, and they frequently blame their symptoms on other medical conditions. However, inadequate knowledge impedes prompt diagnosis and efficient therapy.

COVID-19 Impact:

The Circadian Rhythm Sleep Disorder (CRSD) market was impacted by the COVID-19 pandemic in a number of ways. Delays in diagnosing and treating CRSDs occurred during the height of the pandemic due to decreased patient visits, changes in healthcare services, and the prioritization of COVID-19 cases. Patient access to care was impacted by the temporary closure of sleep clinics and the implementation of restrictions on their operations. Additionally, a rise in sleep disorders was attributed to changes in lifestyle and psychological stress brought on by the pandemic.

The Light Box segment is expected to be the largest during the forecast period

In the market for circadian rhythm sleep disorders, the Light Box segment has the largest share. One important non-pharmacological treatment for CRSDs is light therapy, which is frequently given through light boxes. This is especially true for disorders like shift work sleeps disorder and delayed sleep phase disorder. Moreover, bright artificial light produced by light boxes can help reset a person's circadian rhythms by simulating sunlight. They are extensively utilized to successfully manage CRSD symptoms in both clinical and domestic contexts. Because light therapy is widely used in CRSD treatment plans and is both non-invasive and effective, it has a significant market share in the "Light Box" category.

The Wellness Centers & Spa segment is expected to have the highest CAGR during the forecast period

The Circadian Rhythm Sleep Disorder (CRSD) market is expected to grow at the highest CAGR in the Wellness Centers & Spa segment. A growing number of wellness centers and spas are adding sleep health services to their menus, such as relaxation therapies and CRSD-focused treatments. Additionally, these environments offer a comprehensive strategy for treating sleep disorders, emphasizing relaxation and general well-being. People are going to wellness centers and spas for specialized treatments and therapies as awareness of the link between sleep and wellbeing increases.

Region with largest share:

In terms of market share for Circadian Rhythm Sleep Disorder (CRSD), North America, which includes the United States and Canada, usually has the largest share. Moreover, the region's established healthcare system, prodigious R&D endeavours, high incidence of sleep disorders, and growing consciousness regarding the importance of sleep health are the main causes of this dominance. Due to its high level of affluence and high rate of sleep disorders, the region leads the CRSD market and serves as a hub for innovations and developments in the field of sleep medicine.

Region with highest CAGR:

In the Circadian Rhythm Sleep Disorder (CRSD) market, the Asia-Pacific region is projected to have the highest CAGR. The region's strong growth is ascribed to various factors, including growing consciousness regarding sleep hygiene, the increasing occurrence of CRSDs as a result of evolving lifestyles, and the development of healthcare facilities. A greater emphasis on general health and well-being, coupled with the expansion of economies in the Asia-Pacific region, is driving demand for creative approaches to sleep disorders. Additionally, the Asia-Pacific CRSD market has experienced rapid growth due to factors such as urbanization, rising healthcare expenditures, and the region's expanding middle class. This has positioned the market as a dynamic and rapidly expanding segment with significant potential for future development.

Key players in the market

Some of the key players in Circadian Rhythm Seep Disorder market include: Carex Health, The Sunbox Company, Garmin Ltd., BMC Medical Co., Ltd, Teva Pharmaceutical Industries Ltd., Natus Medical Incorporated , Koninklijke Philips N.V., Mylan N.V., Vanda Pharmaceuticals Inc., Neuraxpharm, Sunrise System , Beurer GmbH, Lanaform N.V., Samarit Medical AG, Takeda Pharmaceutical Company, Northern Light Technologies , RedMed Inc. , ActiGraph, LLC, Verilux, Inc. and Akeda Pharmaceutical Company Limited .

Key Developments:

In August 2023, Garmin Ltd., announced it has entered into a definitive agreement to acquire JL Audio, a privately-held U.S. company that designs and manufactures audio solutions for marine, aftermarket automotive, powersports, home and RV customers.

In July 2023, Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and Alvotech, a global biotech company specializing in the development and manufacture of biosimilars, expanded their existing strategic partnership agreement. Teva will also acquire subordinated convertible bonds to be issued by Alvotech.

In December 2022, Natus Medical announced that it entered into a definitive agreement to acquire neurophysiology solution provider Micromed. Middleton, Wisconsin-based Natus expects the transaction to close in early 2023. The company elected not to disclose the financial terms of the deal. It marks the first transaction made by the company since its $1.2 billion acquisition by the ArchiMed group in July.

Treatment Types Covered:

  • Therapeutic Devices
  • Light Box
  • Desk Lamps
  • Light Visor
  • Dawn Simulator
  • Diagnostic Devices
  • Actigraphy Sensors
  • Wrist and Hand Band Actigraphy Devices
  • Wearable Actigraphy Devices
  • Polysomnography Devices
  • Fixed Polysomnography Devices
  • Portable
  • Medications
  • Other Treatment Types

Drug Types Covered:

  • Benzodiazepines
  • Non benzodiazepine Hypnotics
  • Orexin Receptor Antagonists
  • Melatonin Receptor Agonist
  • Modafinil
  • Tasimelteon
  • Other Drug Types

Ages Covered:

  • Children
  • Adults
  • Elders

Distribution Channels Covered:

  • Institutional Sales
  • Retail Sales

Applications Covered:

  • Delayed Sleep Phase Syndrome
  • Advanced Sleep Phase Syndrome
  • Non-24-h sleep-wake syndrome
  • Irregular Sleep-Wake Disorder
  • Shift Work Disorder
  • Jet Lag
  • Other Applications

End Users Covered:

  • Home Care Settings
  • Wellness Centers & Spa
  • Sleep Testing Centers
  • Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Circadian Rhythm Seep Disorder Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Therapeutic Devices
  • 5.3 Light Box
  • 5.4 Desk Lamps
  • 5.5 Light Visor
  • 5.6 Dawn Simulator
  • 5.7 Diagnostic Devices
  • 5.8 Actigraphy Sensors
  • 5.9 Wrist and Hand Band Actigraphy Devices
  • 5.10 Wearable Actigraphy Devices
  • 5.11 Polysomnography Devices
  • 5.12 Fixed Polysomnography Devices
  • 5.13 Portable
  • 5.14 Medications
  • 5.15 Other Treatment Types

6 Global Circadian Rhythm Seep Disorder Market, By Drug Type

  • 6.1 Introduction
  • 6.2 Benzodiazepines
  • 6.3 Non benzodiazepine Hypnotics
  • 6.4 Orexin Receptor Antagonists
  • 6.5 Melatonin Receptor Agonist
  • 6.6 Modafinil
  • 6.7 Tasimelteon
  • 6.8 Other Drug Types

7 Global Circadian Rhythm Seep Disorder Market, By Age

  • 7.1 Introduction
  • 7.2 Children
  • 7.3 Adults
  • 7.4 Elders

8 Global Circadian Rhythm Seep Disorder Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Institutional Sales
  • 8.3 Retail Sales

9 Global Circadian Rhythm Seep Disorder Market, By Application

  • 9.1 Introduction
  • 9.2 Delayed Sleep Phase Syndrome
  • 9.3 Advanced Sleep Phase Syndrome
  • 9.4 Non-24-h sleep-wake syndrome
  • 9.5 Irregular Sleep-Wake Disorder
  • 9.6 Shift Work Disorder
  • 9.7 Jet Lag
  • 9.8 Other Applications

10 Global Circadian Rhythm Seep Disorder Market, By End User

  • 10.1 Introduction
  • 10.2 Home Care Settings
  • 10.3 Wellness Centers & Spa
  • 10.4 Sleep Testing Centers
  • 10.5 Specialty Clinics
  • 10.6 Other End Users

11 Global Circadian Rhythm Seep Disorder Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Carex Health
  • 13.2 The Sunbox Company
  • 13.3 Garmin Ltd.
  • 13.4 BMC Medical Co., Ltd
  • 13.5 Teva Pharmaceutical Industries Ltd.
  • 13.6 Natus Medical Incorporated
  • 13.7 Koninklijke Philips N.V.
  • 13.8 Mylan N.V.
  • 13.9 Vanda Pharmaceuticals Inc.
  • 13.10 Neuraxpharm
  • 13.11 Sunrise System
  • 13.12 Beurer GmbH
  • 13.13 Lanaform N.V.
  • 13.14 Samarit Medical AG
  • 13.15 Takeda Pharmaceutical Company
  • 13.16 Northern Light Technologies
  • 13.17 RedMed Inc.
  • 13.18 ActiGraph, LLC
  • 13.19 Verilux, Inc.
  • 13.20 Akeda Pharmaceutical Company Limited

List of Tables

  • Table 1 Global Circadian Rhythm Seep Disorder Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Circadian Rhythm Seep Disorder Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 3 Global Circadian Rhythm Seep Disorder Market Outlook, By Therapeutic Devices (2021-2030) ($MN)
  • Table 4 Global Circadian Rhythm Seep Disorder Market Outlook, By Light Box (2021-2030) ($MN)
  • Table 5 Global Circadian Rhythm Seep Disorder Market Outlook, By Desk Lamps (2021-2030) ($MN)
  • Table 6 Global Circadian Rhythm Seep Disorder Market Outlook, By Light Visor (2021-2030) ($MN)
  • Table 7 Global Circadian Rhythm Seep Disorder Market Outlook, By Dawn Simulator (2021-2030) ($MN)
  • Table 8 Global Circadian Rhythm Seep Disorder Market Outlook, By Diagnostic Devices (2021-2030) ($MN)
  • Table 9 Global Circadian Rhythm Seep Disorder Market Outlook, By Actigraphy Sensors (2021-2030) ($MN)
  • Table 10 Global Circadian Rhythm Seep Disorder Market Outlook, By Wrist and Hand Band Actigraphy Devices (2021-2030) ($MN)
  • Table 11 Global Circadian Rhythm Seep Disorder Market Outlook, By Wearable Actigraphy Devices (2021-2030) ($MN)
  • Table 12 Global Circadian Rhythm Seep Disorder Market Outlook, By Polysomnography Devices (2021-2030) ($MN)
  • Table 13 Global Circadian Rhythm Seep Disorder Market Outlook, By Fixed Polysomnography Devices (2021-2030) ($MN)
  • Table 14 Global Circadian Rhythm Seep Disorder Market Outlook, By Portable (2021-2030) ($MN)
  • Table 15 Global Circadian Rhythm Seep Disorder Market Outlook, By Medications (2021-2030) ($MN)
  • Table 16 Global Circadian Rhythm Seep Disorder Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 17 Global Circadian Rhythm Seep Disorder Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 18 Global Circadian Rhythm Seep Disorder Market Outlook, By Benzodiazepines (2021-2030) ($MN)
  • Table 19 Global Circadian Rhythm Seep Disorder Market Outlook, By Non benzodiazepine Hypnotics (2021-2030) ($MN)
  • Table 20 Global Circadian Rhythm Seep Disorder Market Outlook, By Orexin Receptor Antagonists (2021-2030) ($MN)
  • Table 21 Global Circadian Rhythm Seep Disorder Market Outlook, By Melatonin Receptor Agonist (2021-2030) ($MN)
  • Table 22 Global Circadian Rhythm Seep Disorder Market Outlook, By Modafinil (2021-2030) ($MN)
  • Table 23 Global Circadian Rhythm Seep Disorder Market Outlook, By Tasimelteon (2021-2030) ($MN)
  • Table 24 Global Circadian Rhythm Seep Disorder Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 25 Global Circadian Rhythm Seep Disorder Market Outlook, By Age (2021-2030) ($MN)
  • Table 26 Global Circadian Rhythm Seep Disorder Market Outlook, By Children (2021-2030) ($MN)
  • Table 27 Global Circadian Rhythm Seep Disorder Market Outlook, By Adults (2021-2030) ($MN)
  • Table 28 Global Circadian Rhythm Seep Disorder Market Outlook, By Elders (2021-2030) ($MN)
  • Table 29 Global Circadian Rhythm Seep Disorder Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 30 Global Circadian Rhythm Seep Disorder Market Outlook, By Institutional Sales (2021-2030) ($MN)
  • Table 31 Global Circadian Rhythm Seep Disorder Market Outlook, By Retail Sales (2021-2030) ($MN)
  • Table 32 Global Circadian Rhythm Seep Disorder Market Outlook, By Application (2021-2030) ($MN)
  • Table 33 Global Circadian Rhythm Seep Disorder Market Outlook, By Delayed Sleep Phase Syndrome (2021-2030) ($MN)
  • Table 34 Global Circadian Rhythm Seep Disorder Market Outlook, By Advanced Sleep Phase Syndrome (2021-2030) ($MN)
  • Table 35 Global Circadian Rhythm Seep Disorder Market Outlook, By Non-24-h sleep-wake syndrome (2021-2030) ($MN)
  • Table 36 Global Circadian Rhythm Seep Disorder Market Outlook, By Irregular Sleep-Wake Disorder (2021-2030) ($MN)
  • Table 37 Global Circadian Rhythm Seep Disorder Market Outlook, By Shift Work Disorder (2021-2030) ($MN)
  • Table 38 Global Circadian Rhythm Seep Disorder Market Outlook, By Jet Lag (2021-2030) ($MN)
  • Table 39 Global Circadian Rhythm Seep Disorder Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 40 Global Circadian Rhythm Seep Disorder Market Outlook, By End User (2021-2030) ($MN)
  • Table 41 Global Circadian Rhythm Seep Disorder Market Outlook, By Home Care Settings (2021-2030) ($MN)
  • Table 42 Global Circadian Rhythm Seep Disorder Market Outlook, By Wellness Centers & Spa (2021-2030) ($MN)
  • Table 43 Global Circadian Rhythm Seep Disorder Market Outlook, By Sleep Testing Centers (2021-2030) ($MN)
  • Table 44 Global Circadian Rhythm Seep Disorder Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 45 Global Circadian Rhythm Seep Disorder Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.